Introduction
Arachidonic acid AA is a polyunsaturated omega-fatty acid, which is the second most abundant PUFA in the epidermis, accounting for approximately of total epidermal fatty acids . AA is also recognized as the precursor of certain types of eicosanoids that are metabolized to a wide range of biologically and clinically important signaling molecules by enzymes including cyclooxygenase COX and lipoxygenase LOX . Since these eicosanoids derived from AA are thought to be pro-inflammatory, COX and LOX are the therapeutic target for some diseases with inflammation. In the fields of pharmacological study, ear edema caused by topical application of AA has been widely used to evaluate COX and -LOX inhibitors , .
TRPV is a member of the vanilloid family of transient receptor cation channels . Although the expression of TRPV is detected in brain, spinal cord, and dorsal root ganglion, it has been indicated to be highly expressed in skin, primarily in hair follicles and in keratinocytes that are present in the basal layer of the epidermis , . Therefore, the dermatological roles of TRPV have been previously reported. Our group reported that TRPV has an important role as a dendritic and mast cell modulator in the development of dermatitis in rodents , . TRPV is activated by an endogenous mediator such as farnesyl pyrophosphate, which is an intermediate metabolite of the mevalonate pathway, and by synthesized ligands such as -aminoethoxydiphenyl borate , . Interestingly, it has been newly discovered that AA and other unsaturated fatty acids are the potentiator of TRPV activity . Furthermore, TRPV is activated by temperature with a threshold of -, , . Conversely, the pro-resolving lipid mediator R -resolvin D derived from omega-PUFA such as docosahexaenoic acid inhibits TRPV activity .
Although it is known that the metabolites of AA cause ear edema and AA activates TRPV , it is not clear whether AA directly evokes edema through TRPV . In this study, we investigated whether TRPV is involved in the development of ear edema caused by AA using pharmacological or histological methods and the global analysis of oxidized fatty acids.
Abstract: Arachidonic acid (AA) plays a pivotal role in the development of edema via its oxidized metabolites derived from cyclooxygenase (COX) and lipoxygenase (LOX), and is recently recognized as an activator of TRPV3. However, it is not clear whether AA plays some TRPV3-mediated pathological roles in the development of edema. Pharmacological and histological studies using ICR TRPV3+/+ and ICR TRPV3-/-mice indicated that higher ear edema responses to topical application of AA were observed in ICR TRPV3+/+ mice compared with ICR TRPV3-/-mice. However, there was no difference in the ear edema response to 12-Otetradecanoylphorbol 13-acetate, skin histology, and skin barrier function between these mouse strains. Furthermore, oxidized fatty acids from the lesional site were analyzed to elucidate the TRPV3-mediated pathological roles of AA, and the results revealed that there were no differences in the level of COX or LOX metabolites derived from AA between both mouse strains. We concluded that AA plays a role in the development of TRPV3-mediated ear edema and that this result may contribute to better understanding of the pathophysiological mechanisms involved in the development of a certain type of edema.
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Experimental
. Mice C BL TRPV -/-mice were constructed according to a previous report . C BL TRPV -/-mice were crossed with ICR mice for several generations to produce ICR TRPV -/-mice, because ICR mice are useful for analyzing ear edema. Mice were maintained in micro-isolator cages, exposed to a -h light/ -h dark cycle, and provided with standard feed and water ad libitum. The experiments were performed in compliance with institutional guidelines and approved by the institutional animal care and use committee.
. Skin barrier function The percentage of barrier recovery was calculated using the following formula: transepidermal water loss TEWL immediately after tape stripping TEWL at the indicated timepoint / TEWL immediately after tape stripping TEWL before tape stripping . TEWL of mouse dorsal skin treated with tape stripping was measured just before, immediately after, and , and hours after using a Tewameter Courage and Khazaka Electronic GmbH, Koln, Germany as previously described , .
. Ear edema We induced ear edema using -O-tetradecanoylphorbol -acetate TPA or AA in mice with and without TRPV according to the procedure shown in Fig. 1 . TPA was dissolved in acetone at .
or . w/v , and each mouse was treated with µL TPA on both sides of an ear. Ear thickness was measured using a thickness gauge Mitutoyo, Kawasaki, Japan at , , , and hours after TPA treatment. AA was dissolved in acetone at or w/v , and each mouse was treated with µL AA on both sides of an ear. Ear thickness was measured using the thickness gauge at , , , , and minutes after AA treatment.
After the last measurement, paraffin sections were prepared from skin samples obtained from mice. The sections were stained with hematoxylin and eosin and/or acidic toluidine blue for histopathological analysis by light microscopy. Paraffin sections were also prepared for immunohistochemical analyses. These sections were pretreated with . µg/mL of purified mouse IgG BD Biosciences, San Diego, CA, USA in phosphate-buffered saline PBS containing bovine serum albumin and Dako Protein Block Dako, Glostrup, Denmark . Next, the sections were immunostained with a rat anti-mouse CD antibody A ; BD Biosciences . After washing in PBS, the sections were treated with biotin-conjugated secondary antibodies BD Biosciences , washed with PBS, and treated with UltraAvidin-Horseradish Peroxidase Leinco Technology Inc., St. Louis, MO, USA . Finally, antibody-positive cells in the sections were visualized by enzyme-based color staining after washing with PBS. Sections stained with acidic toluidine blue were used for counting the numbers of mast cells, and CD staining was used for counting the numbers of CDbearing T cells.
. Global analysis for oxidized AA Previously, we developed a method for analyzing fatty . In this study, we made substantial improvements to this method to increase its sensitivity for detecting AA metabolites.
Briefly, ears were treated with AA, collected after minutes, and stored at until lipid extraction. After preparation of mass fraction homogenates with mM dibutyl hydroxytoluene in MeOH/ultrapure water / , v/v using a Micro Smash TM MS-R Tomy Seiko Co., Ltd., Tokyo, Japan at , rpm for minutes at , µL of IS working solution was added to µL aliquots of the ear homogenates along with µL MeOH. The mixtures were vortex mixed vigorously for minutes at and then centrifuged at , g for min at . The upper layer was transferred to a silicone-coated tube, dried under a gentle stream of nitrogen at , and reconstituted in µL MeOH. Next, the MeOH solution and µL of mM potassium phosphate solution pH . were mixed and placed directly into a preactivated MonoSpin TM C -AX column GL Sciences Inc., Tokyo, Japan . The column was centrifuged at , g for minutes at and then washed with µL of a NaCl solution by centrifugation. Finally, analytes that had adsorbed onto the column were eluted twice with µL of formic acid in MeOH. The eluate was dried under a gentle stream of nitrogen at , reconstituted in µL MeOH, and µL was introduced into the liquid chromatography-tandem mass spectrometry LC-MS/MS system.
Lipid separation was performed on an Acquity UPLC system Waters Corp., Milford, MA, USA and achieved with an Acquity UPLC BEH C column mm . mm i.d., . µm; Waters Corp. . The autosampler and column were maintained at and , respectively. Mobile phase A was water/ mM phosphoric acid/acetic acid / / , v/v/v and mobile phase B was acetonitrile/isopropanol/acetic acid / / , v/v/v at a flow rate of . mL/min. The gradient program was . -. minutes from to B , . -. minutes B and . -. minutes B . An FCV-AH system Shimadzu, Kyoto was used as a valve switch to allow for introduction of the sample to the separation column between . and . minutes. MS analysis was carried out in scheduled multiple reaction monitoring MRM mode using an API Mass Spectrometer AB SCIEX, Foster City, CA, USA equipped with an ESI source. Nitrogen was used as the collision gas for all metabolites. Oxidized fatty acids were detected in negative ESI mode with the following source parameters: curtain gas, psi; ion source gas , psi; ion source gas , psi; ionspray voltage, V; collision gas, psi; temperature, ; interface heater, on ; entrance potential, V; collision cell exit potential, V; MRM detection window, s; target scan time, second. Acquisition and processing of data were performed with Analyst v . . AB Sciex . MRM conditions for each molecule are summarized in Table S1 .
. Statistical analysis
Comparisons between groups were performed using the Tukey-Kramer test. SAS v . software SAS Institute, Cary, NC, USA was used for all the statistical analyses. p . was considered as significant, and all data are shown as the mean standard error of the mean.
Results
. Comparison of the skin barrier function between mouse strains If deficient TRPV causes defective skin barrier functions in rodents, it is too difficult to estimate the pathological roles of AA via TRPV using ICR TRPV -/-mice with transdermal administration. First, we investigated the impact of TRPV changes on TEWL in dorsal skins of ICR TRPV +/+ and ICR TRPV -/-mice by tape stripping. There were no differences in TEWL after tape stripping between the mouse strains Fig. 2 . Next, the skin barrier function of the mice was evaluated by determining the TEWL values. Skin barriers disrupted by tape stripping recovered with the same kinetics in both mouse strains data not shown . Therefore, the strategy of using TRPV -deficient mice was suitable for investigating skin responses to topical AA and -O-tetradecanoylphorbol -acetate TPA with little regard to differences in the skin barrier function between the mouse strains.
. Comparison of the ear edema response to TPA between mouse strains Based on the results from the recovering kinetics of the skin barrier after tape stripping, we determined that ICR TRPV +/+ and ICR TRPV -/-mice were operable for the comparison of the ear edema response to TPA, a diester of phorbol that is ordinarily used in biomedical research to activate the signal transduction enzyme protein kinase C . Therefore, we next induced ear edema with topical application of TPA in ICR TRPV +/+ and ICR TRPV -/-mice to demonstrate that a certain type of edema could be evoked in both mouse strains, because we were concerned about the constitutive inhibitory effect of this ion channel s deficiency on the development of edema. We measured ear thickness at , , , and hours after TPA treatment Fig.  3a and calculated the area under the curve AUC Fig.  3b . Prominently thickened ears were observed in both mouse strains at and hours following application of .
or . TPA compared with untreated mice Fig.  3a and 3b . There were no differences in ear thickness between the mouse strains Fig. 3a and 3b . These results demonstrated that ear edema could be induced by topical Fig. 3 Comparison of the ear edema response to TPA between both mouse strains. Ear swelling was observed at several time points in both mouse strains receiving TPA compared with those not receiving TPA a , and Furthermore, we carried out histological analysis using these mouse strains, since a previous study demonstrated that T cells play an important role in the development of hapten-stimulated edema and mast cells are mandatory components for the development of AA-induced ear edema. Histological analysis indicated that there were no differences in CD -bearing T cell or mast cell numbers between the mouse strains Fig. 3c , Considering these pharmacological and histological results without qualitative and quantitative differences between both mouse strains, TRPV deficiency did not result in an innate lack of ear edema responses and we concluded that topical application of AA to ICR TRPV +/+ and ICR TRPV -/-mice seems to be suitable to investigate their physiological role via TRPV .
. Comparison of the ear edema response to AA between mouse strains We induced ear edema with the topical application of AA in ICR TRPV +/+ and ICR TRPV -/-mice to investigate the role of AA via TRPV in the development of edema. We measured ear thickness at , , , , and minutes after application and calculated the AUC Fig 4b . Prominently thickened ears were observed in treated ICR TRPV +/+ mice compared with untreated mice after and AA application Fig. 4a and 4b . Prominently thickened ears were also observed in treated ICR TRPV -/-mice compared with untreated ICR TRPV -/-mice after AA application Fig. 4a  and 4b . Next, we compared the AUCs for both mouse strains receiving the same treatments. Results indicated that the ear edema in ICR TRPV +/+ mice was significantly more severe than that in ICR TRPV -/-mice.
Topical application of AA to the ears of mice causes immediate edema at -minutes onward. Since it is clear that the onset of the edema coincides with extravasation of tissue fluid via the vascular wall, we carried out histological analysis using both mouse strains to investigate the role of TRPV in the development of AA-induced edema. In Fig.  4c , prominent cellular infiltrations were not observed in Fig. 4 Comparison of the ear edema response to AA between both mouse strains. Ear swelling was observed at several time points in both mouse strains receiving AA compared with those not receiving AA a , and AUCs were calculated b . both mouse strains with AA treatment compared with those without the treatment. However, we observed prominent vacuola, which were thought to be caused by extravasation of tissue fluid, in both mouse strains after the AA treatment and a lower dermal vacuola response in mice without TRPV compared with those with TRPV . These findings indicated that TRPV might play an aggravating role in the development of AA-induced ear edema.
. Pro ling of oxidized AA in mouse ears with and without AA treatment We previously reported methods to analyze fatty acids and their oxidized metabolites . In this study, we improved our method to increase its sensitivity, because it is difficult to analyze oxidized fatty acids from small tissue samples. By changing the composition of the mobile phase, the sensitivity of this method improved by at least five-fold compared with the previous method. For example, the peak intensities of LTB , PGE , PGD and , -EET were improved at . e . e LTB , . e . e PGE , . e
. e PGD and . e . e , -EET , respectively Fig. S1 . Furthermore, the signal-to-noise ratios of LTB , PGE , PGD and , -EET were improved at . . LTB , . . PGE , . . PGD , and . , -EET , respectively. Using this established method, we measured AA and its metabolites in ears from both mouse strains with and without AA application at min after treatment. The amount of AA and its metabolites was significantly higher in mice with AA treatment than in those without AA treatment Fig. 5 . Interestingly, there were no differences in these amounts, including COX and LOX metabolites, between ICR TRPV +/+ mice and ICR TRPV -/-mice treated with AA Fig. 5 . These results indicated that TRPV itself might directly aggravate AA-induced ear edema rather than increased COX and LOX metabolites.
Discussion
We previously reported that TRPV gain-of-function caused itchy dermatitis and that TRPV deficiency was associated with substantial resistance to pruritus in rodents , ,
. In the present study, we indicated deficient TRPV is essentially no different in the development of a certain type of ear edema compared with sufficient TRPV , since prominent ear edema responses to TPA were observed in both ICR TRPV -/-and ICR TRPV +/+ mice. Furthermore, we indicated that AA could not cause prominent ear edema in ICR TRPV -/-mice compared with ICR TRPV +/+ mice. When TPA was applied to the mouse ear, the vascular permeability paralleled the edemic response and influx of neutrophils. Conversely, when AA was applied to the mouse ear, the vascular permeability preceded the edemic response and neutrophil influx. Furthermore, TPA induced longer lasting edema associated with marked influx of neutrophils, whereas AA induced a short-lived edemic response with rapid onset associated with marked increases in the levels of oxidized fatty acids . These pathways with some distinction between TPA and AA may reflect a biological difference such as the TRPV response. Because of this marked difference in the types of ear edema, we thought Fig. 5 Global analysis of AA metabolites. The profiles of AA and its oxidized metabolites in ear edema after AA application. Ears were collected for lipid analysis at min after edema was induced with the topical application of AA. We measured lipids in lesional skin from both mouse strains using our new method. Values represent means standard error of the mean for five mice. There were no significant differences between mouse strains. that the symptoms caused by AA depend on COX and LOX metabolites to a large degree , . We speculated that loss of TRPV would cause diminished production of these metabolites. Indeed, it was reported that TRP channels might control inflammatory responses in the skin via the production of an AA metabolite such as PGE in keratinocytes .
Another study found that -aminoethoxydiphenyl borate, which is the agonist of TRPV , potentiates heat-evoked PGE release from primary keratinocytes that overexpress TRPV but not from those with normal TRPV levels . Interestingly, the levels of some kinds of AA metabolites, such as EET, , -DHET, , -DHET, LTB , and -keto-PGF α , had a tendency to be different between these mouse strains in AA application groups. However, we did not find any correlation pattern between the degrees of ear edema and the amount of these metabolites. In addition, there were no significant differences in AA metabolite profiles between both mouse strains, which were accountable for the differences in the degrees of this edema, in contrast to our hypothesis. Considering these results of fatty acid analysis in both mouse strains, ear edema caused by AA might be partially due to TRPV in addition to LOX and COX enzymes. At first glance, this hypothesis, as pointed out above, seems to be fair. However, our preliminary data using DS-Nh mice bearing genetically gain-functioned TRPV gly ser indicated that gain-functioned TRPV alone did not cause ear edema without quantitative alteration of AA metabolites Fig. S2a and S2b . However, a greater edema response to a low concentration of AA was observed in mice with gain-functioned TRPV compared with those without. We also found no differences in the levels of COX and LOX metabolites between the mouse strains Fig. S3 . Considering all the data, TRPV seems to be an aggravating factor in the development of AA-induced ear edema. Recently, we compared lipid profiles between rodents with TRPV gly ser and TRPV . Levels of some kinds of AA metabolites such as anandamide, which might play some roles in the development of edema, were different between both strains. Further studies should be carried out to draw a strong conclusion from global analysis of fatty acids at the lesional site.
It was previously reported that TRPV regulates skin barrier formation through epidermal growth factor signaling and might play an important role in wound healing . Based on this information, TRPV -deficient mice might seem to be a problematic model for investigating ear edema caused by topical substances because of difficulties equalizing the quantity of AA and TPA absorbed via the skin in wildtype versus TRPV -deficient mouse strains. Therefore, we investigated the skin barrier function in mice with and without TRPV at various ages. We determined that TRPV is a key player in the skin barrier function in newborn mice but not in older mice. Thus, the current study design was reasonable for evaluating edema caused by topically applied substances.
We previously reported that skin levels of TRPV were higher in atopic dermatitis patients at lesional sites than at non-lesional sites . The amount of TRPV is thought to be critical for the development of certain kinds of dermatitis including atopic dermatitis. Gain-of-function mutations in TRPV were recently identified as the cause of a rare form of palmoplantar keratoderma, Olmsted syndrome, which is a type of genetically heterogeneous genodermatosis , . Cheung et al. reported that TRPV in adipocytes might be a novel therapeutic target for obesity , and our group speculated that TRPV could be a therapeutic target for itching . Although TRPV is highly expressed in the skin, this channel seems to be involved in the development of a variety of diseases and could be an attractive therapeutic target for these human diseases.
Metabolites derived from AA, which are thought to be ligands for G-protein-coupled receptors and TRPV channels , , have a major impact on human health and disease. Therefore, it is important to establish standard methods for analyzing these metabolites to better understand their role in human and animal pathology. Indeed, the skin produces bioactive lipids that participate in physiological and pathological conditions including pro-and anti-inflammation. Detailed methods and results of the profiling of lipid mediators in cutaneous samples were reported in . In this study, we reported a novel global method for analyzing AA metabolites with a LC-MS/MS system. We believe that our established method is a useful tool for investigating and understanding animal and human pathology related to these bioactive lipids.
Conclusion
We found that topical application of AA is an aggravating factor in the development of ear edema via TRPV , a therapeutic target for various diseases. Furthermore, our results contribute to better understanding of the pathophysiological mechanisms involved in the development of a certain type of edema.
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